Folate-equipped nanolipoplexes mediated efficient gene transfer into human epithelial cells

International Journal of Molecular Sciences

Volumn 14, Issue 1, 2013, Pages 1477-1501

  Mornet, Emmanuel ^a,b,c   Carmoy, Nathalie ^a   Lainé, Céline ^b   Lemiègre, Loïc ^a,b   Le Gall, Tony ^a   Laurent, Isabelle ^b   Marianowski, Remi ^c   Férec, Claude ^a   Lehn, Pierre ^a   Benvegnu, Thierry ^a,b   Montier, Tristan ^a,d  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b UNIV RENNES   (France)

^c BREST UNIVERSITY HOSPITAL   (France)

^d CHU MORVAN   (France)

Author keywords

Cationic lipids; Cystic fibrosis; Epithelial cells; Folate receptors; Folic acid; Neutral lipid nanocomplexes

Indexed keywords

CARBOXYLIC ACID; FOLATE RECEPTOR; FOLIC ACID; LIPID; LIPOFECTAMINE; LIPOPLEX; LUCIFERASE; MACROGOL; NANOLIPOPLEX; NANOPARTICLE; PLASMID DNA; UNCLASSIFIED DRUG; FOLATE RECEPTOR 1; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; ENDOCYTOSIS; GENE DELIVERY SYSTEM; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN TARGETING; TRANSGENE; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; HELA CELL LINE; METABOLISM; NOSE CAVITY; PLASMID; PROCEDURES; REPRODUCIBILITY; TRACHEA; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; EPITHELIAL CELLS; FOLATE RECEPTOR 1; FOLIC ACID; HELA CELLS; HUMANS; LIPOSOMES; LUCIFERASES; MICE; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; NASAL CAVITY; PLASMIDS; REPRODUCIBILITY OF RESULTS; TRACHEA; TRANSFECTION;

EID: 84878649078     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14011477     Document Type: Article

References (55)

1. Flotte, T.R. Gene therapy: The first two decades and the current state-of-the-art. J. Cell. Physiol. 2007, 213, 301-305.
2. Edelstein, M.L.; Abedi, M.R.; Wixon, J. Gene therapy clinical trials worldwide to 2007-An update. J. Gene. Med. 2007, 9, 833-842.
3. Ferrer-Miralles, N.; Vázquez, E.; Villaverde, A. Membrane-active peptides for non-viral gene therapy: Making the safest easier. Trends Biotechnol. 2008, 26, 267-275.
4. Ott, M.G.; Seger, R.; Stein, S.; Siler, U.; Hoelzer, D.; Grez, M. Advances in the treatment of Chronic Granulomatous Disease by gene therapy. Curr. Gene Ther. 2007, 7, 155-161.
5. Gould, D.J.; Chernajovsky, Y. Novel delivery methods to achieve immunomodulation. Curr. Opin. Pharmacol. 2007, 7, 445-450.
6. Nikol, S. Therapeutic angiogenesis for peripheral artery disease: Gene therapy. Vasa 2007, 36, 165-173.
7. Koutsilieri, E.; Rethwilm, A.; Scheller, C. The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders. J. Neural. Transm. Suppl. 2007, 72, 43-49.
8. Blaese, R.M.; Culver, K.W.; Miller, A.D.; Carter, C.S.; Fleisher, T.; Clerici, M.; Shearer, G.; Chang, L.; Chiang, Y.; Tolstoshev, P.; et al. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 1995, 270, 475-480.
9. Phases of Gene Therapy Clinical Trials. Available online: http://www.abedia.com/wiley/ phases.php (accessed on 11 January 2013).
10. Baum, C.; Dullmann, J.; Li, Z.; Fehse, B.; Meyer, J.; Williams, D.A.; von Kalle, C. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003, 101, 2099-2114.
11. Cavazzana-Calvo, M.; Thrasher, A.; Mavilio F. The future of gene therapy. Nature 2004, 427, 779-781.
12. Van der Wouden, E.A.; Sandovici, M.; Henning, R.H.; de Zeeuw, D.; Deelman, L.E. Approaches and methods in gene therapy for kidney disease. J. Pharmacol. Toxicol. Methods 2004, 50, 13-24.
13. Gao, X.; Kim, K.S.; Liu, D. Nonviral gene delivery: What we know and what is next. AAPS J. 2007, 9, 92-104.
14. Bally, M.B.; Harvie, P.; Wong, F.M.; Kong, S.; Wasan, E.K.; Reimer, D.L. Biological barriers to cellular delivery of lipid-based DNA carriers. Adv. Drug Delivery Rev. 1999, 38, 291-315.
15. Montier, T.; Delépine, P.; Pichon, C.; Férec, C.; Porteous, D.J.; Midoux, P. Non-viral vectors in cystic fibrosis gene therapy: Progress and challenges Trends Biotechnol. 2004, 22, 586-592.
16. Montier, T.; Benvegnu, T.; Jaffrès, P.A.; Yaouanc, J.J.; Lehn, P. Progress in cationic lipid-mediated gene transfection: A series of bio-inspired lipids as an example. Curr. Gene Ther. 2008, 8, 296-312.
17. Billiet, L.; Gomez, J.P.; Berchel, M.; Jaffrès, P.A.; Le Gall, T.; Montier, T.; Bertrand, E.; Cheradame, H.; Guégan, P.; Mével, M.; et al. Gene transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes and lipopolyplexes in a myoblast cell line. Biomaterials 2012, 33, 2980-2990.
18. Midoux, P.; Breuzard, G.; Gomez, J.P.; Pichon, C. Polymer-based gene delivery: A current review on the uptake and intracellular trafficking of polyplexes. Curr. Gene Ther. 2008, 8, 335-352.
19. Prokop, A.; Davidson, J.M. Nanovehicular intracellular delivery systems. J. Pharm. Sci. 2008, 97, 3518-3590.
20. Kakudo, T.; Chaki, S.; Futaki, S.; Nakase, I.; Akaji, K.; Kawakami, T.; Maruyama, K.; Kamiya, H.; Harashima, H. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: An artificial viral-like delivery system. Biochemistry 2004, 43, 5618-5628.
21. Kawakami, S.; Hattori, Y.; Lu, Y.; Higuchi, Y.; Yamashita, F.; Hashida, M. Effect of cationic charge on receptor-mediated transfection using mannosylated cationic liposome/plasmid DNA complexes following the intravenous administration in mice. Pharmazie 2004, 59, 405-408.
22. Montier, T.; Delépine, P.; Benvegnu, T.; Ferrieres, V.; Miramon, M.-L.; Dagorn, S.; Guillaume, C.; Plusquellec, D.; Ferec, C. Efficient gene transfer into human epithelial cell lines using glycosylated cationic carriers and neutral glycosylated co-lipids. Blood Cells Mol. Dis. 2004, 32, 271-282.
23. Erbacher, P.; Remy, J.S.; Behr, J.P. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 1999, 6, 138-145.
24. Gupta, A.S.; Huang, G.; Lestini, B.J.; Sagnella, S.; Kottke-Marchant, K.; Marchant, R.E. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system. Thromb. Haemostasis 2005, 93, 106-114.
25. Bareford, L.M.; Swaan, P.W. Endocytic mechanisms for targeted drug delivery. Adv. Drug. Delivery Rev. 2007, 59, 748-758.
26. Lacey, S.W.; Sanders, J.M.; Rothberg, K.G.; Anderson, R.G.; Kamen, B.A. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Invest. 1989, 84, 715-720.
27. Luhrs, C.A.; Slomiany, B.L. A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail, J. Biol. Chem. 1989, 264, 21446-21449.
28. Low, P.S.; Henne, W.A.; Doorneweerd, D.D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 2008, 41, 120-129.
29. Yoshiyuki, H.; Yoshie, M. Folate-linked lipid-based nanoparticles for tumor-targeted gene therapy. Nanotechnol. Life Sci. 2007, 1, 270-298.
30. Zhao, X.; Li, H.; Lee, R.J. Targeted drug delivery via the folate receptors. Expert Opin. Drug Delivery 2008, 5, 309-319.
31. Jaracz, S.; Chen, J.; Kuznetsova, L.V.; Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg. Med. Chem. 2005, 13, 5043-5054
32. Matsue, H.; Rothberg, K.G.; Takashima, A.; Kamen, B.A.; Anderson, R.G.; Lacey, S.W. Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc. Natl. Acad. Sci. USA 1992, 89, 6006-6009.
33. Sabharanjak, S.; Mayor, S. Folate receptor endocytosis and trafficking. Adv. Drug Delivery Rev. 2004, 56, 1099-1109.
34. Martin, B.; Sainlos, M.; Aissaoui, A.; Oudrhiri, N.; Hauchecorne, M.; Vigneron, J.P.; Lehn, J.M.; Lehn, P. The design of cationic lipids for gene delivery. Curr. Pharm. Des. 2005, 11, 375-394.
35. Dorin, J.R.; Farley, R.; Webb, S.; Smith, S.N.; Farini, E.; Delaney, S.J.; Wainwright, B.J.; Alton, E.W.; Porteous, D.J. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther. 1996, 3, 797-801.
36. Kim, S.H.; Mok, H.; Jeong, J.H.; Kim, S.W.; Park, T.G. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug. Chem. 2006, 17, 241-244.
37. Dai, J.; Zou, S.; Pei, Y.; Cheng, D.; Ai, H.; Shuai, X. Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery. Biomaterials 2011, 32, 1694-1705.
38. Goula, D.; Benoist, C.; Mantero, S.; Merlo, G.; Levi, G.; Demeneix, B.A. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. 1998, 5, 1291-1295.
39. Beyerle, A.; Braun, A.; Merkel, O.; Koch, F.; Kissel, T.; Stoeger, T. Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice. J. Control. Release 2011, 151, 51-56.
40. Gilot, D.; Miramon, M.-L.; Benvegnu, T.; Ferrieres, V.; Loreal, O.; Guguen-Guillouzo, C.; Plusquellec, D.; Loyer, P. Cationic lipids derived from glycine betaine promote efficient and non-toxic gene transfection in cultured hepatocytes, J. Gene Med. 2002, 4, 415-427.
41. Lainé, C.; Mornet, E.; Lemiégre, L.; Montier, T.; Cammas-Marion, S.; Neveu, C.; Lehn, P.; Benvegnu, T. Folate-equipped pegylated archaeal lipid derivatives: Synthesis and transfection properties. Chem. Eur. J. 2008, 14, 8330-8340.
42. Portier, Y.; Lainé, C.; Lemiegre, L.; Montier, T.; Cammas-Marion, S.; Lehn, P.; Benvegnu, T. Folate PEGylated archael lipids: Cells targeting and drug delivery. J. Control. Release 2010, 148, 115-116.
43. Martinez-Veracoechea, F.J.; Frenckel, D. Designing super selectivity in multivalent nano-particle binding. Proc. Natl. Acad. Sci. USA 2011, 108, 10963-10968.
44. Toffoli, G.; Cernigoi, C.; Russo, A.; Gallo, A.; Bagnoli, M.; Boiocchi, M. Overexpression of folate binding protein in ovarian cancers. Int. J. Cancer (Pred. Oncol.) 1997, 74, 193-198.
45. Simmons, G.; Rennekamp, A.J.; Chai, N.; Vandenberghe, L.H.; Riley, J.L.; Bates P. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J. Virol. 2003, 77, 13433-13438.
46. Reddy, J.A.; Low, P.S. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J. Control. Release 2000, 64, 27-37.
47. Cho, K.C.; Kim, S.H.; Jeong, J.H.; Park, T.G. Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. Macromol. Biosci. 2005, 5, 512-519.
48. Lee, R.J.; Low, P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 1994, 269, 3198-3204.
49. Leamon, C.P.; DePrince, R.B.; Hendren, R.W. Folate-mediated drug delivery: Effect of alternative conjugation chemistry. J. Drug Target 1999, 7, 157-169.
50. Felgner, P.L.; Gadek, T.R.; Holm, M.; Roman, R.; Chan, H.W.; Wenz, M.; Northrop, J.P.; Ringold, G.M.; Danielsen, M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 1987, 84, 7413-7417.
51. Ghaghadaa, K.B.; Saul, J.; Natarajan, J.V.; Bellamkonda, R.V.; Annapragada, A.V. Folate targeting of drug carriers: A mathematical model. J. Control. Release 2005, 104, 113-128.
52. Lee, E.R.; Marshall, J.; Siegel, C.S.; Jiang, C.; Yew, N.S.; Nichols, M.R.; Nietupski, J.B.; Ziegler, R.J.; Lane, M.B.; Wang, K.X.; et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 1996, 10, 1701-1710.
53. Picquet, E.; Le Ny, K.; Delepine, P.; Montier, T.; Yaouanc, J.J.; Cartier, D.; des Abbayes, H.; Ferec, C.; Clement, J.C. Cationic lipophosphoramidates and lipophosphoguanidines are very efficient for in vivo DNA delivery. Bioconjug. Chem. 2005, 16, 1051-1053.
54. Montier, T.; Delepine, P.; Marianowski, R.; Le Ny, K.; Le Bris, M.; Gillet, D.; Potard, G.; Mondine, P.; Frachon, I.; Yaouanc, J.J.; et al. CFTR transgene expression in primary DeltaF508 epithelial cell cultures from human nasal polyps following gene transfer with cationic phosphonolipids. Mol. Biotechnol. 2004, 26, 193-206.
55. Reddy, J.A.; Dean, D.; Kennedy, M.D.; Low, P.S. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J. Pharm. Sci. 1999, 88, 1112-1118.